Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899140-25-000718
Filing Date
2025-05-20
Accepted
2025-05-20 16:16:39
Documents
1
Period of Report
2025-05-08

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 2730
  Complete submission text file 0000899140-25-000718.txt   4560
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
MetaVia Inc. (Issuer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 64, CHEONHO-DAERO DONGDAEMUN-GU SEOUL M5 02587
Business Address 64, CHEONHO-DAERO DONGDAEMUN-GU SEOUL M5 02587 82-2-920-8184
DONG-A ST CO., LTD (Reporting) CIK: 0001799260 (see all company filings)

State of Incorp.: M5 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37809 | Film No.: 25969007